Home›Compare›Collective vs Midi Health

Collective vs Midi Health: Which Is Better?

Head-to-head comparison of Collective and Midi Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Midi Health scores higher overall in our independent evaluation (74.8/100 vs 68.6/100), leading on trust & safety, experience, product range, reputation. Collective comes out ahead on value. Collective has the lower entry price (from $17/mo vs $50/mo), so the better value depends on which treatment you need.

Collective is a new GLP-1 weight-loss service from Thrive Market founder Gunnar Lovelace. It sells compounded semaglutide at $59/mo and tirzepatide at $69/mo at every dose, plus a $199 annual membership.

Visit Collective

Insurance-billed virtual clinic for perimenopause and menopause, prescribing FDA-approved and compounded HRT, non-hormonal options, and GLP-1s through menopause-trained clinicians.

Visit Midi Health

Score Breakdown

DimensionCollectiveMidi Health
Overall Score68.6/10074.8/100 ✓
Trust & Safety30%66/10078/100 ✓
Value25%90/100 ✓72/100
Experience20%70/10074/100 ✓
Product Range15%45/10072/100 ✓
Reputation10%55/10078/100 ✓

At a Glance

Founded—2021
Headquarters—Menlo Park, CA
Publicly tradedNoNo
Treatment categories13
Treatments listed33
Starting price$17/mo$50/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryCollectiveMidi Health
Weight Loss / GLP-1$17
Annual Membership
$50–$250
Branded GLP-1 Prescribing (Wegovy/Zepbound)

Collective

+Lowest all-in compounded GLP-1 pricing we track: $59/mo semaglutide or $69/mo tirzepatide plus $199/yr membership (about $76–86/mo)
+Flat pricing at every dose, so the monthly cost does not climb during titration
+Membership includes unlimited physician messaging, quarterly dose reviews and registered-dietitian access
−Dispensing pharmacies, medical group and headquarters are not disclosed. The site only says 'state-licensed US pharmacies'
−Very short track record: 38 Trustpilot reviews and no independent press coverage beyond the founder's profile
−GLP-1 weight loss only, with no branded Wegovy/Zepbound option for patients who want FDA-approved product
Read the full Collective review →

Midi Health

+In-network with most major commercial PPO plans, which third-party reviewers put at roughly $50 out of pocket per visit
+Clinicians trained specifically in menopause care, prescribing both FDA-approved HRT and non-hormonal options and ordering labs and imaging
+No membership fee; self-pay is per visit ($250 first, $150 follow-up), which is cheaper than a monthly plan for patients on a stable regimen
−Billing is the dominant complaint: BBB logs 64 complaints in three years, mostly surprise balances after insurance confirmations
−Medicare, Medicaid and Medi-Cal are not accepted, excluding many women in the core menopause age group
−Compounded GLP-1 pricing is published only as a 'from $164 per 4-week supply' floor; dose-level prices require a visit
Read the full Midi Health review →

Collective vs Midi Health — FAQ

Is Collective better than Midi Health?

▾

Midi Health scores higher overall in our independent evaluation (74.8/100 vs 68.6/100), leading on trust & safety, experience, product range, reputation. Collective comes out ahead on value. Collective has the lower entry price (from $17/mo vs $50/mo), so the better value depends on which treatment you need.

Is Collective or Midi Health cheaper?

▾

Collective has the lower starting price (from $17/mo vs $50/mo for Midi Health). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Collective and Midi Health both offer?

▾

Both platforms treat Weight Loss / GLP-1. Collective covers 1 treatment category total and Midi Health covers 3.

Still deciding?